QNCX Competitors & Alternatives
Compare Quince Therapeutics, Inc. Common Stock with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
QNCX
Main Stock$0.16
Tradestie Score
53
Market Cap
$87.02M
Analyst Upside
+2967.5%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$340.00
|
$160.70B | 24.1 | 54 | Compare |
|
GILD
Gilead Sciences Inc
|
$138.80
|
$137.92B | 20.7 | 57 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$765.43
|
$46.96B | 38.3 | 55 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.62
|
$24.57B | - | 53 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$175.61
|
$22.61B | 19.6 | 51 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$130.90
|
$13.59B | 28.4 | 64 | Compare |
|
EXEL
Exelixis Inc
|
$43.99
|
$11.09B | 15.8 | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$50.11
|
$10.74B | - | 58 | Compare |
|
QGEN
QIAGEN N.V.
|
$40.13
|
$10.04B | 20.0 | 59 | Compare |
|
TECH
Bio-Techne Corp.
|
$53.83
|
$9.33B | 101.5 | 58 | Compare |
More QNCX Analysis
Data updated: Apr 08, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry